Colistimethate Sodium
Chemical Structure
Overview
Colistimethate sodium is a prodrug. It is produced by the reaction of colistin with formaldehyde and sodium bisulfite, which leads to the addition of a sulfomethyl group to the primary amines of colistin. Colistimethate sodium is less toxic than colistin when administered parenterally. In aqueous solutions, it undergoes hydrolysis to form a complex mixture of partially sulfomethylated derivatives, as well as colistin.
Key Features
- Molecular Formula C58H105N16Na5O28S5
- Therapeutic Category Antibiotics
- Dose Form Injectable
Use In
-
Pseudomonas Aeruginosa Infection
Colistimethate sodium may be used to treat Pseudomonas aeruginosa infections in patients with cystic fibrosis, and it has come into recent use for treating multidrug-resistant Acinetobacter infection, although resistant forms have been reported. Colistimethate sodium has also been given intrathecally and intraventricularly in Acinetobacter baumannii and Pseudomonas aeruginosa meningitis and ventriculitis
| Open Part | Close Part | IP | BP | USP | EP |
|---|---|---|---|---|---|
| Under preparation | Under preparation |  |
|
|
|